Clinical Trial Update: Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating paclitaxel-coated PTCA balloons for treatment of in-stent restenosis has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Restenosis

Drugs mentioned

• Paclitaxel-coated PTCA balloons (paclitaxel-coated balloon)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Coronary Restenosis | Phase 1, Phase 2 | Status: COMPLETED